Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Profound Medical Corp (PROF)

Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Profound Medical Corp 2400 SKYMARK AVENUE UNIT 6 MISSISSAUGA A6 L4W 5K5 CAN

www.profoundmedical.com Employees: 142 P: 64-7476-1350 F: 647-847-3739

Sector:

Medical

Description:

Profound Medical Corp. is a medical technology company. It is focused on a therapeutics platform which provides the precision of real-time Magnetic Resonance Imaging technology for the incision-free ablation of diseased tissue. The company principally commercialized the TULSA-PRO(R) and Sonalleve(R) platforms. Profound Medical Corp. is based in Mississauga, Canada.

Key Statistics

Overview:

Market Capitalization, $K 298,337
Enterprise Value, $K 248,087
Shares Outstanding, K 36,294
Float, K 35,742
% Float 98.48%
Short Interest, K 1,216
Short Float 3.35%
Days to Cover 5.47
Short Volume Ratio 0.39
% of Insider Shareholders 1.52%
% of Institutional Shareholders 47.86%

Financials:

Annual Sales, $ 10,680 K
Annual Net Income, $ -27,820 K
Last Quarter Sales, $ 5,290 K
Last Quarter Net Income, $ -7,980 K
EBIT, $ -42,650 K
EBITDA, $ -41,710 K

Growth:

1-Year Return 10.63%
3-Year Return -31.39%
5-Year Return -68.31%
5-Year Revenue Growth 156.12%
5-Year Earnings Growth 18.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/13/25
Next Earnings Date 03/05/26
Earnings Per Share ttm -1.34
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 31.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/16/19

PROF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -86.18%
Return-on-Assets % -70.55%
Profit Margin % -260.49%
Debt/Equity 0.14
Price/Sales 16.69
Price/Cash Flow N/A
Price/Book 7.83
Book Value/Share 1.06
Interest Coverage -0.20
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar